查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1878103

脑脊髓液（CSF）管理市场－2025-2030年预测

Cerebrospinal Fluid (CSF) Management Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球脑脊髓液 (CSF) 管理市场预计将从 2025 年的 858,859,000 美元成长到 2030 年的 1,076,454,000 美元，复合年增长率为 4.62%。

脑脊髓液（CSF）是存在于大脑和脊髓中的重要液体，提供必要的机械和免疫保护。对脑脊髓液进行有效管理对于治疗脑脊髓液异常积聚引起的疾病至关重要。脑脊髓液管理装置，包括引流系统和分流器，旨在控制和引导脑脊髓液从脑室流出，从而预防水脑症等併发症。由于全球医疗保健趋势的协同作用，这些装置的市场正在显着扩张。

推动市场成长的关键因素包括新兴经济体神经专科医院的建立以及旨在提供更具成本效益的治疗方案的持续投资。此外，全球神经系统疾病盛行率的不断上升也是一个潜在的驱动力。同时，人口老化加剧、开发中国家可支配收入的增加以及医疗基础设施的不断进步，也推动了微创手术的高需求和日益增长的趋势。用于治疗各种神经血管疾病的新型技术改良产品的推出，也为市场创造了盈利的成长前景。

然而，市场扩张也面临许多限制因素。其中一项主要挑战是全球合格神经外科医生短缺，鑑于老年人口快速增长，对高品质神经系统护理的需求日益增加，这一问题尤其严峻。此外，脑脊髓液分流术相关併发症（特别是装置故障和感测器相关感染疾病）的增加，预计将成为限制市场成长的主要问题。这些专用医疗设备的高成本也进一步阻碍了其广泛应用，尤其是在对成本较为敏感的市场。

市场区隔分析

依产品类型：

全球脑脊髓液管理市场分为外部引流系统和分流器两大类。预计分流器市场将主导整个产业。这一主导地位归因于全球分流手术数量的不断增长，以及因装置故障和感染疾病导致的翻修手术数量的相应增加。现代分流系统在降低翻修手术率和缩短平均住院时间的优势，是推动此细分市场扩张的主要因素。

按最终用户划分：

市场分为成人、儿童和老年三个细分市场。儿童市场预计将占据相当大的市场份额，这主要是由于先天性水脑症在儿童群体中的发病率不断上升，以及为治疗该疾病及相关疾病而对儿童进行的大量分流手术所致。

按行业划分：

按医院、诊所和其他机构进行分析，预计医院部门将占据相当大的市场份额，并以最快的速度扩张，因为大量复杂的脑脊髓液管理病例，尤其是在老年人群体中，都是在医院环境中治疗的，而医院集中了所需的外科专业知识和基础设施。

区域市场展望

市场按地理区域划分包括北美、南美、欧洲、中东和非洲以及亚太地区。

亚太地区预计将实现最高成长率。这项加速成长主要得益于蓬勃发展的医疗旅游业、先天性脑水脑症盛行率的上升以及各国人口老化加剧。此外，持续进行的研究合作以及政府主导的旨在提升神经系统疾病治疗水平的投资，也是推动该地区市场扩张的关键因素。

北美市场预计也将显着成长，这主要得益于研究机构为推动神经系统疾病治疗所采取的策略性倡议。健全的法规结构有利于新型治疗方法的核准，加上全球主要市场参与者的稳固地位，为区域市场的扩张提供了强而有力的支撑。该地区领先医疗设备公司的集中布局，确保了创新和商业活动的持续发展。

主要市场趋势

脑脊髓液管理领域正经历快速变革，其驱动力来自于旨在提升诊断和治疗能力的策略联盟和监管发展。近期趋势凸显了製药和医疗设备公司携手合作，开发将治疗药物直接输送至脑脊髓液的一体化解决方案。此外，新诊断测试的监管核准也提升了我们识别和测量阿兹海默症神经系统疾病病理过程的能力，从而提高了诊断准确性并有助于监测治疗进展。这些倡议体现了业界致力于透过伙伴关係和技术整合实现创新，从而更好地支持患有严重神经系统疾病的患者。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探索市场驱动因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
  • 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

企业使用我们的报告做什么？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2022年至2024年的历史数据和2025年至2030年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入成长和预测评估，包括国家/地区
  • 公司概况（策略、产品、财务资讯、关键发展等）

全球脑脊髓液（CSF）管理市场细分及分析如下：

  • 脑脊髓液 (CSF) 市场按产品类型划分
  • 脑脊髓液分流术
  • 外部排水系统
  • 脑脊髓液（CSF）市场按最终用户划分
  • 儿童
  • 成人
  • 老年人
  • 脑脊髓液 (CSF) 市场按行业划分
  • 医院
  • 诊所
  • 其他的
  • 脑脊髓液 (CSF) 市场（按地区划分）
  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
  • 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 脑脊髓液 (CSF) 市场按产品类型划分

  • 介绍
  • 脑脊髓液分流术
  • 外部排水系统

6. 按最终用户分類的脑脊髓液 (CSF) 市场

  • 介绍
  • 儿童
  • 成人
  • 老年人

7. 按行业垂直领域分類的脑脊髓液 (CSF) 市场

  • 介绍
  • 医院
  • 诊所
  • 其他的

8. 脑脊髓液 (CSF) 市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Medtronic
  • Integra LifeSciences
  • Johnson & Johnson MEDTECH
  • B. Braun Melsungen AG
  • Spiegelberg GmbH & Co. KG（Acquired by SHS Medizintechnik Holding GmbH）
  • Sophysa（A subsidiary of tkb group）
  • Natus Medical Incorporated（Acquired by ArchiMed Group）
  • Argi Grup
  • Moller Medical GMBH
  • Delta Surgical
  • Wellong Instruments Co., Ltd.

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611877

The global cerebrospinal fluid (CSF) management market, with a 4.62% CAGR, is expected to grow to USD 1,076.454 million by 2030 from USD 858.859 million in 2025.

Cerebrospinal fluid (CSF) is a vital bodily fluid found in the brain and spinal cord, providing essential mechanical and immunological protection. The management of this fluid is critical in treating conditions involving its improper accumulation. CSF management devices, which include drainage systems and shunts, are designed to control and divert the flow of CSF away from the brain's ventricles, thereby preventing complications such as hydrocephalus. The market for these devices is experiencing significant expansion, driven by a confluence of global healthcare trends.

Key factors propelling market growth include the development of specialized neuro-hospitals in emerging economies and ongoing investments aimed at delivering more cost-effective treatments. Furthermore, the growing global prevalence of neurological disorders is a fundamental driver. This is compounded by a high and increasing demand for minimally invasive surgical procedures, a trend fueled by a growing geriatric population, rising disposable incomes in developing nations, and continuous advancements in healthcare infrastructure. The introduction of new, technologically improved products for treating various neurovascular illnesses is also creating lucrative growth prospects for the market.

However, the market's expansion faces significant constraints. A primary challenge is the global scarcity of qualified neurosurgeons, a workforce shortage that is particularly acute given the rapidly increasing senior population requiring quality neurological care. Additionally, rising complications associated with CSF shunts, including device malfunctions and sensor-related infections, are major issues predicted to limit growth. The high cost of these specialized medical devices further hampers widespread adoption, especially in cost-sensitive markets.

Market Segment Analysis

By Product Type:

The global cerebrospinal fluid management market is segmented into external drainage systems and shunts. The shunts segment is expected to dominate the industry. This dominance is attributable to the rising number of shunting procedures performed worldwide and a corresponding increase in revision shunt surgeries necessitated by device malfunction or infection. The advantages of modern shunt systems, which offer a reduced likelihood of revision surgery and shorter average hospital stays, are key factors fueling this segment's expansion.

By End-Users:

The market is divided into adult, pediatric, and geriatric segments. The pediatric category is estimated to account for a considerable market share. This is fuelled by the increased prevalence of congenital hydrocephalus in the pediatric population and a high volume of shunting procedures performed on children to manage this and other related conditions.

By Industry:

Analyzed across hospitals, clinics, and other settings, the hospital segment is anticipated to hold a sizable market share and expand at the quickest rate. This is due to the large number of complex CSF management cases, particularly within the aging population, being treated in hospital environments where the necessary surgical expertise and infrastructure are concentrated.

Geographical Market Outlook

A geographical segmentation of the market includes North America, South America, Europe, the Middle East and Africa, and the Asia Pacific.

The Asia Pacific region is expected to grow at the highest rate. This accelerated growth is driven by developing medical tourism, a rising prevalence of congenital hydrocephalus, and a growing geriatric population in various nations. Furthermore, ongoing research collaborations and government-backed investments aimed at bolstering treatment for neurological disorders are significant drivers of regional market expansion.

North America is also expected to see considerable growth, fueled by strategic efforts undertaken by research institutes to advance the treatment of neurological conditions. The presence of a robust regulatory framework that facilitates the approval of new treatments, coupled with the well-established presence of major global market players, acts as a powerful catalyst for regional market expansion. The concentration of leading medical device companies in this region ensures a steady pipeline of innovation and commercial activity.

Key Market Developments

The cerebrospinal fluid management landscape is dynamic, characterized by strategic partnerships and regulatory advancements aimed at improving diagnostic and therapeutic capabilities. Recent developments highlight a trend towards collaboration between pharmaceutical and device companies to create integrated solutions for delivering therapies directly to the CSF. Furthermore, regulatory clearances for new diagnostic assays are enhancing the ability to define and measure pathological processes in neurological diseases like Alzheimer's, thereby improving diagnosis and treatment monitoring. These activities reflect an industry focused on innovation through partnership and technological convergence to better serve patients with severe neurological conditions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The Global Cerebrospinal Fluid (CSF) Management market is segmented and analyzed as follows:

  • CEREBROSPINAL FLUID (CSF) MARKET BY PRODUCT TYPE
  • CSF Shunts
  • External Drainage System
  • CEREBROSPINAL FLUID (CSF) MARKET BY END-USER
  • Pediatric
  • Adult
  • Geriatric
  • CEREBROSPINAL FLUID (CSF) MARKET BY INDUSTRY
  • Hospital
  • Clinics
  • Others
  • CEREBROSPINAL FLUID (CSF) MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CEREBROSPINAL FLUID (CSF) MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. CSF Shunts
  • 5.3. External Drainage System

6. CEREBROSPINAL FLUID (CSF) MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Pediatric
  • 6.3. Adult
  • 6.4. Geriatric

7. CEREBROSPINAL FLUID (CSF) MARKET BY INDUSTRY

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Clinics
  • 7.4. Others

8. CEREBROSPINAL FLUID (CSF) MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Medtronic
  • 10.2. Integra LifeSciences
  • 10.3. Johnson & Johnson MEDTECH
  • 10.4. B. Braun Melsungen AG
  • 10.5. Spiegelberg GmbH & Co. KG (Acquired by SHS Medizintechnik Holding GmbH)
  • 10.6. Sophysa (A subsidiary of tkb group)
  • 10.7. Natus Medical Incorporated (Acquired by ArchiMed Group)
  • 10.8. Argi Grup
  • 10.9. Moller Medical GMBH
  • 10.10. Delta Surgical
  • 10.11. Wellong Instruments Co., Ltd.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations